Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach cramps at night on Wegovy are a recognised side effect of semaglutide. Clinical trial data show gastrointestinal discomfort — including cramping and nausea — is most common in the early weeks of treatment and after each dose increase, because semaglutide slows how quickly the stomach empties. Night-time timing often reflects the cumulative effect of the day's meals on a slowed digestive system. These symptoms are usually temporary, and most people find them manageable with a few practical adjustments. That said, severe or persistent stomach pain always warrants a call to your prescriber or, if the pain is acute and reaches into your back, urgent medical attention. Wegovy is a prescription-only medicine; a prescriber decides whether it is appropriate for you and can help you through the side effects.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 clinical trial (which underpins Wegovy's UK licence) found that gastrointestinal side effects were the most frequently reported adverse events in the semaglutide 2.4 mg group, with nausea, diarrhoea, vomiting and constipation all appearing more often than in the placebo group, as documented in the STEP 1 paper in the New England Journal of Medicine. If you are wondering whether semaglutide gives you stomach cramps, cramping and abdominal discomfort sit within this broader GI picture and the short answer is that they are a recognised and well-documented response. The mechanism is well understood: semaglutide acts on GLP-1 receptors in the gut wall and brain, and one of its effects is to slow how fast food travels through your stomach and into the small intestine. That is partly how it reduces appetite. The trade-off is that undigested food can sit in a stalled stomach far longer than usual, producing gas, pressure and pain.
The NHS semaglutide medicines page notes that these effects are most noticeable at the start of treatment and after each dose step, and that they typically ease within a couple of weeks as the body adjusts. That pattern is important: if cramps are worst in your first few days on a new dose and then fade, that is the expected course. If they persist well beyond the two-week mark or worsen, that is a reason to speak to your prescriber rather than wait it out.
In January 2026 the MHRA issued a Drug Safety Update specifically on GLP-1 medicines, highlighting acute pancreatitis as an infrequent but serious risk. The distinguishing feature is severe, persistent abdominal pain (often radiating to the back) that does not ease. If you want to understand what sets this apart from routine side effects, our guide to Wegovy stomach cramps explains how ordinary cramping from a slowed gut tends to feel different, typically colicky, coming in waves, and easing after passing wind or visiting the bathroom, whereas pancreatitis pain is steadier and more intense. If you are ever unsure which you are experiencing, treat it as urgent and seek medical help.
A question our prescribers hear regularly: why does the discomfort tend to arrive in the evening or disturb sleep, rather than hitting first thing? The answer has more to do with timing than with semaglutide doing something different after dark. By the time evening comes, the stomach has been processing food all day under the influence of a drug that significantly slows that process. The largest meal of the day (usually dinner) then arrives on top of an already-busy digestive system. Trapped gas and fermentation in the gut produce pressure that builds over hours.
When you lie down, that pressure redistributes. Stomach acid moves more easily towards the oesophagus, and gas that was sitting in one part of the gut shifts. Horizontal positioning removes gravity's help in moving contents along. The result is that people who felt only mild discomfort during the afternoon can find themselves woken at 2 a.m. by quite sharp cramping. If your weekly injection falls on a Monday (or on a Friday if you tend to have bigger meals at weekends) you may notice the correlation between injection day plus two or three days and the worst of the night symptoms. That is roughly when peak semaglutide concentration is driving the strongest slowdown in gastric motility.
Understanding this pattern helps, because it means the fix often lies in daytime choices rather than doing anything differently at bedtime. You can read more about how timing and food choices affect cramps in the days after your Wegovy injection to build a clearer picture of your personal pattern.
The evidence-based adjustments start with meal size. A smaller evening meal (ideally finishing eating two to three hours before you plan to sleep) gives the stomach more time to move its contents along before you lie down. High-fat foods are the biggest culprit for delayed gastric emptying even without semaglutide; on treatment, a rich or oily evening meal can take considerably longer than usual to clear. Carbonated drinks add gas to an already gassy system. Eating slowly and chewing thoroughly reduces the volume of air swallowed.
Position matters too. Lying on your left side is thought to help stomach contents drain into the small intestine more readily than lying on the right. Elevating the head of the bed slightly reduces acid reflux, which often accompanies cramping on GLP-1 medicines. Some people find a short, gentle walk after dinner makes a noticeable difference; vigorous exercise immediately after eating is a different matter and can make things worse.
If you are finding the cost of managing this privately (or weighing up whether treatment is worth continuing) the Wegovy pricing page explains what is included in a transparent private prescription and what questions to ask any provider. The more important point is that persistent or worsening cramps should always prompt a conversation with your prescriber before you decide to adjust or stop treatment.
On the medicine itself, a prescriber may consider whether slowing the dose-increase schedule could help if symptoms are severe. Cramping on Wegovy more broadly is covered in a separate explainer if you want to understand the full side-effect picture across all doses.
Most night-time cramping on Wegovy is uncomfortable rather than dangerous, and settles on its own. There are situations, though, where you should not wait for your next scheduled check-in. Get same-day medical advice if cramps are severe and do not ease within an hour or two, if the pain radiates to your back or shoulder, if you have a fever alongside the stomach pain, if you cannot keep fluids down, or if you notice your skin or the whites of your eyes turning yellow.
Prolonged vomiting and diarrhoea also carry a dehydration risk that can affect kidney function, so if GI symptoms are severe enough to stop you drinking normally for more than 24 hours, call 111 or your GP rather than waiting. For any urgent query with the nurse or prescriber team at nume, the support line is available seven days a week.
If you are considering starting Wegovy and want to understand the full safety picture before committing, our semaglutide overview covers the mechanism, evidence, eligibility and what clinical oversight looks like at each stage of treatment. And if you have questions not covered here, the FAQs address many of the most common queries about GLP-1 treatment. When you are ready to speak to a prescriber, start your free consultation and a GPhC-registered clinician will review your situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.